These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [The cloning and expression of human secreted interleukin 2 receptor alpha chain gene in eukaryotic cells]. Cheng X; Du K; Heng F; Wu N; Shen Y Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Oct; 17(5):326-32. PubMed ID: 8706165 [TBL] [Abstract][Full Text] [Related]
44. Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1. Takeuchi K; Holloway WG; McKinzie JH; Suter TM; Statnick MA; Surface PL; Emmerson PJ; Thomas EM; Siegel MG; Matt JE; Wolfe CN; Mitch CH Bioorg Med Chem Lett; 2007 Oct; 17(19):5349-52. PubMed ID: 17720493 [TBL] [Abstract][Full Text] [Related]
45. Chronic morphine exposure during puberty induces long-lasting changes in opioid-related mRNA expression in the mediobasal hypothalamus. Byrnes EM Brain Res; 2008 Jan; 1190():186-92. PubMed ID: 18083149 [TBL] [Abstract][Full Text] [Related]
46. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice. Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907 [TBL] [Abstract][Full Text] [Related]
47. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling. Wang HY; Friedman E; Olmstead MC; Burns LH Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657 [TBL] [Abstract][Full Text] [Related]
48. Properties of a kappa-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual G alpha subunit and is similar to that of other opioid receptors. Prather PL; McGinn TM; Claude PA; Liu-Chen LY; Loh HH; Law PY Brain Res Mol Brain Res; 1995 Apr; 29(2):336-46. PubMed ID: 7609621 [TBL] [Abstract][Full Text] [Related]
49. The mechanism involved in the repression of the mu opioid receptor gene expression in CEM x174 cells infected by simian immunodeficiency virus. Liu H; Li H; Guo L; Li C; Li M; Jiang W; Liu X; McNutt MA; Li G J Leukoc Biol; 2009 Apr; 85(4):684-91. PubMed ID: 19164126 [TBL] [Abstract][Full Text] [Related]
50. Baicalein protects chicken embryonic cardiomyocyte against hypoxia-reoxygenation injury via mu- and delta- but not kappa-opioid receptor signaling. Tu IH; Yen HT; Cheng HW; Chiu JH Eur J Pharmacol; 2008 Jul; 588(2-3):251-8. PubMed ID: 18511038 [TBL] [Abstract][Full Text] [Related]
51. Binding studies of novel, non-mammalian enkephalins, structures predicted from frog and lungfish brain cDNA sequences. Bojnik E; Magyar A; Tóth G; Bajusz S; Borsodi A; Benyhe S Neuroscience; 2009 Jan; 158(2):867-74. PubMed ID: 18977279 [TBL] [Abstract][Full Text] [Related]
52. The human macrophage mannose receptor is not a professional phagocytic receptor. Le Cabec V; Emorine LJ; Toesca I; Cougoule C; Maridonneau-Parini I J Leukoc Biol; 2005 Jun; 77(6):934-43. PubMed ID: 15767290 [TBL] [Abstract][Full Text] [Related]
53. Comparison of opioid receptor distributions in the rat central nervous system. Gray AC; Coupar IM; White PJ Life Sci; 2006 Jul; 79(7):674-85. PubMed ID: 16546223 [TBL] [Abstract][Full Text] [Related]
54. Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene. Cadet P; Mantione KJ; Stefano GB J Immunol; 2003 May; 170(10):5118-23. PubMed ID: 12734358 [TBL] [Abstract][Full Text] [Related]
55. The proteins interacting with C-terminal of μ receptor are identified by bacterial two-hybrid system from brain cDNA library in morphine-dependent rats. Zhou P; Jiang J; Dong Z; Yan H; You Z; Su R; Gong Z Life Sci; 2015 Dec; 143():156-67. PubMed ID: 26522050 [TBL] [Abstract][Full Text] [Related]
56. Characterization of the murine mu opioid receptor gene. Kaufman DL; Keith DE; Anton B; Tian J; Magendzo K; Newman D; Tran TH; Lee DS; Wen C; Xia YR J Biol Chem; 1995 Jun; 270(26):15877-83. PubMed ID: 7797593 [TBL] [Abstract][Full Text] [Related]
57. Effect of electromagnetic field on cyclic adenosine monophosphate (cAMP) in a human mu-opioid receptor cell model. Ross CL; Teli T; Harrison BS Electromagn Biol Med; 2016; 35(3):206-13. PubMed ID: 26151161 [TBL] [Abstract][Full Text] [Related]
58. Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. Bare LA; Mansson E; Yang D FEBS Lett; 1994 Nov; 354(2):213-6. PubMed ID: 7957926 [TBL] [Abstract][Full Text] [Related]
59. Differential expression of the human mu opiate receptor from different primary vascular endothelial cells. Cadet P; Mantione KJ; Bilfinger TV; Stefano GB Med Sci Monit; 2004 Oct; 10(10):BR351-5. PubMed ID: 15448587 [TBL] [Abstract][Full Text] [Related]
60. Kinetics of beta-funaltrexamine binding to wild-type and mutant mu-opioid receptors expressed in Chinese hamster ovary cells. Spivak CE; Beglan CL Synapse; 2004 May; 52(2):123-35. PubMed ID: 15034918 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]